Hans Michael Haitchi

University Hospital Southampton NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

27h-index2.8kcitations138works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(87), Neonatal Respiratory Health Research(24), Respiratory and Cough-Related Research(17), Inhalation and Respiratory Drug Delivery(12), Chronic Obstructive Pulmonary Disease (COPD) Research(11)

Publications138 total

Multimorbidity phenotypes and associated characteristics in severe asthma: an observational study of European severe asthma registries
The Lancet Regional Health - Europe·2026Open Access
Ex and in vivo testing of human anti-ADAM33 oligonucleotides for novel asthma therapy
2025
Evaluation of the effect of multimorbidity on difficult-to-treat asthma using a novel score (MiDAS): a multinational study of asthma cohorts
The Lancet Respiratory Medicine·2025· 6 citedOpen Access
Targeting ADAM33 with oligonucleotides in complex mouse and human lung tissue explant culture models as a novel disease-modifying asthma therapy
2025
ADAM33
Handbook of Proteolytic Enzymes·2025
Circulating Nitrite in Severe Asthma: Just Another Biomarker or Novel Treatment Target?
Allergy·2024Open Access
Booster vaccination normalizes postvaccination immunity in patients with severe asthma
Journal of Allergy and Clinical Immunology·2024· 1 citedOpen Access
Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma
European Respiratory Journal·2024· 14 citedOpen Access
S126 Testing anti-ADAM33 oligonucleotides in complex mouse and human lung tissue as a novel disease-modifying asthma therapy
2024· 1 cited
M3 The symptomatic benefit from asthma biologics is not sustained throughout the dosing schedule
2024
M9 The impact of an asthmatic maternal environment in pregnancy (MEP) on mediators predisposing to development of early-life asthma
2024
P24 Reduction in background asthma medication following initiation of biologic therapy
2024
S56 Using ABC (adherence, biomarkers and co-morbidity) in the nurse-led asthma clinic to reduce inappropriate use of steroids and antibiotic in patients with breathlessness
2024
S106 Do older people with severe asthma respond to asthma biologics?
2024
Maintenance oral steroids are not required in severe asthma
ERJ Open Research·2024Open Access
The symptomatic benefit from asthma biologics is not sustained throughout the dosing schedule
2024
Title: Do older patients with severe asthma respond to asthma biologics?
2024
The impact of an asthmatic Maternal Environment in Pregnancy (MEP) on mediators predisposing to development of early-life asthma.
2024
Understanding the impact of breathing pattern disorders in difficult-to-treat asthma
Expert Review of Respiratory Medicine·2024· 1 citedOpen Access
Preserved antibody responses to COVID-19 vaccination and lower odds of developing COVID-19 in adults with severe asthma
The Journal of Allergy and Clinical Immunology In Practice·2024· 3 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Donna E. Davies(24), Peter Howarth(23), Stephen T. Holgate(19), Ramesh Kurukulaaratchy(14), Ratko Djukanović(10), John W. Holloway(8), Adnan Azim(8), Anna Freeman(8), Paddy Dennison(8), Jeffrey A. Whitsett(7), Clair Barber(7), David I. Wilson(6), Robert M. Powell(6), Colin Newell(6), Elizabeth R. Davies(5), Heena Mistry(5), Syed Hasan Arshad(5), Tom Wilkinson(5), David Sammut(4), Susan J. Wilson(4)